RE: Hi all!16 Dec 2025 09:54
Sparkythecat,
A fair question — and a sensible one to ask before the crowd arrives.
I don’t screen for “stories” or thematic hype. I look for evidence of transition — companies moving from optionality to execution. The process is fairly systematic:
1) Balance sheet first, always
Early growth only matters if the company can survive long enough to realise it. I look for manageable debt, improving net cash trends, and funding that supports development rather than simply plugging holes.
2) Operational inflection points
I focus on change, not absolute size:
first meaningful production or revenue step-changes in grades, recoveries, or unit costs
capacity expansions that are already funded, regulatory or permitting milestones that materially de-risk the asset
These are the moments where the risk profile shifts — often before valuation catches up.
3) Cash generation > forecasts
I place far more weight on actual cash flow trends than broker models. Even modest, early free cash flow can completely re-rate a small cap if it proves the business model works.
4) Management behaviour, not promises. I watch what management do, not what they say: capital discipline, dilution history, delivery against timelines, and whether guidance quietly tightens rather than constantly resets.
5) Market neglect
The most attractive early-stage growth often sits in that awkward zone where:
Institutions can’t yet buy in size
Retail hasn’t noticed
Liquidity is thin but improving
That’s usually where mispricing lives.
6) Relative comparison, not isolation
Finally, I benchmark against peers that are one or two years further along the curve. If similar assets are re-rated sharply after hitting certain milestones, that provides a useful roadmap for what the market may eventually pay for.
In short, I’m not trying to predict the next fashionable name — I’m trying to identify when the risk has already fallen, but the price hasn’t yet adjusted. AAZ and ATYM simply happen to tick several of those boxes at the moment.